Moisson Montréal Rolls Out the Red Carpet and Awards $2 Million in Grants to 69 Heroes of Food Assistance
MONTREAL, May 27, 2025 (GLOBE NEWSWIRE) — This morning at the Jean-Talon Market, where it all began 40 years ago, Moisson Montréal concluded its 40th anniversary celebrations by awarding $2,048,311 in grants to 69 community agencies. These grants will fund the purchase of basic equipment like refrigerators, cold storage units, vehicles, crates, and tables, essential and concrete tools to better nourish Montrealer's living in precarious situations.
To mark this important gesture, Moisson Montréal symbolically rolled out a red carpet. Not to celebrate prestige, but to honor those who, far from the spotlight yet at the heart of the action, work every day to support the most vulnerable.
'This isn't a glamorous event. What we are awarding today are fridges, stoves, and trucks. But behind each of these pieces of equipment lies an essential gesture toward food dignity. Today, we are celebrating the real heroes working in the frontline,' said Chantal Vézina, Executive Director of Moisson Montréal.
A Powerful Response to Pressing Needs
A total of 162 project proposals were received, reflecting a community sector under strain — rich in ideas but limited by resources. The high quality of submissions highlighted the scale of needs: outdated or missing basic equipment, spaces needing renovation, and delivery capacity to be strengthened. More than $5 million would have been needed to fund all submissions.
The selection was carried out by an independent committee composed of individuals from diverse backgrounds in food security, applying rigorous criteria to prioritize project diversity, tangible impact, and territorial equity.
'We received solid, meaningful, human proposals. The selection process was heart-wrenching. Most of the projects deserved funding. That's why our Board of Directors decided to extend funding beyond the initial plan,' added Ms. Vézina.
A Gesture Made Possible Thanks to The Rossy Foundation
The grants were made possible through a major philanthropic donation from The Rossy Foundation, bolstered by a vote from Dollarama employees who helped direct The Rossy Foundation's funding to Moisson Montréal. This collective gesture raised $1.3 million, which was supplemented by Moisson Montréal's own funds.
A Map Showcasing Impact Across All Boroughs
A geographic map installed onsite allows visitors to visualize the projects supported throughout Montreal's boroughs. Each point represents a concrete solution driven by a community-based organization.
This morning, 69 faces of resilience walked the red carpet. No trophies. Just everyday heroes feeding the vulnerable.
For more information, please contact:
Éliane LaroucheSenior Advisor, Communications and Public AffairsMoisson Montréal514 701-4206
[email protected]
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Cycurion Reports Financial Results for the First Quarter 2025
MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) ('Cycurion' or the 'Company'), a trusted leader in IT cybersecurity solutions and AI, reports financial results for the first quarter ended March 31, 2025, and provides a corporate update. Financial Highlights Revenues of $3.9 million. Gross Profit of $677,673, up 95.4% year-over-year, with a 17.5% gross margin increase in the first quarter of 2025 compared to $346,714 (8.2% gross margin) in the first quarter of 2024, reflecting a focus on capturing and retaining more profitable business. Adjusted EBITDA of $245,062 (6.3% margin) in the first quarter of 2025 compared to $(68,803) in the first quarter of 2024, reflecting strong cost management coupled with both scalable operating leverage and an optimized service mix that included a higher proportion of enterprise clients and stronger government relationships, leading to a significant improvement in adjusted EBITDA in the first quarter of 2025. Net loss of $(10.2) million, consisting of $9.3 million in non-recurring pre-tax charges of non-cash stock compensation expenses and $1.2 million in merger-related expenses, compared to $(0.3) net loss in the first quarter of 2024. Net loss per share of $(0.56) basic and fully diluted that included the aforementioned non-recurring significant pre-tax charges, compared to $(0.02) in the first quarter of 2024. Q1 2025 and Recent Strategic, Technological and Corporate Milestones Listed and Began Trading on Nasdaq: Completed a business combination with Western Acquisition Ventures Corp. in February 2025 and had its shares of common stock listed on the Nasdaq Global Select Market. Broader Rollout of AI-driven SaaS ARx Cybersecurity Platform: High margin, AI-driven cybersecurity solutions have been instrumental in driving margin expansion, enhancing operational scale and strengthening Cycurion's market position, offering advanced capabilities to a wider array of clients. Strategic Partnerships Delivering Results: Long-term partnerships forged in both the public and private sectors are beginning to yield tangible revenue-generating opportunities. These collaborations validate Cycurion's go-to-market strategy and enhance its credibility within the industry. Notably, partnerships have already resulted positively. Includes SOC as Service, External Attack Surface Management, Web Application Firewall and Virtual CISO Support & Consulting. Backlog Reaching Record Levels: Witnessing a robust increase in its backlog of contracted work, which has reached record levels the first quarter of 2025, reflecting strong client demand for Cycurion's scalable solutions, indicating a positive outlook for future revenue streams. New Contracts: Secured a $22 million multi-year contract with State Police Agency. Management CommentaryKevin Kelly, Cycurion CEO, stated, 'As we look ahead, we remain optimistic about the continued demand for our high-margin services and innovative solutions. The company is committed to leveraging the growing client backlog and the success of the ARx platform to drive further growth. Additionally, our focus on nurturing strategic partnerships will be crucial in expanding our market presence and creating new revenue opportunities. Cycurion is poised for a strong 2025, driven by a strategic overhaul focused on sustainable growth and innovation. Over the past year, the company streamlined operations, significantly cutting General and Administrative (G&A) expenses while boosting gross profit for greater financial strength. We have invested heavily in AI-driven technology, sharpening its competitive edge. By pivoting away from low-margin clients to high-value opportunities, the Company has built a robust framework for organic growth while paving the way for expansion, entering 2025 with clear momentum and vision.' About CycurionBased in McLean, Virginia, Cycurion (Nasdaq: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare and corporate clients with a commitment to securing the digital future. Forward Looking StatementsThis press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion's business. Many factors could cause Cycurion's actual results, performance, or achievements to be materially different from any future results, performance, or achievements described in this press release, including words such as 'continue', 'expect', 'intend', 'will', 'hope', 'should', 'would', 'may', 'potential', and other similar expressions. Such factors could include, among others, those detailed in its Registration Statement on Form S-1 and in its Annual Report on Form 10-K, each as filed with the Securities and Exchange Commission (the 'SEC'). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled 'Risk Factors' in those filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and Cycurion does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. Cycurion cannot assure that such statements will prove to be accurate as actual results, and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and, accordingly, investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein. Investor Contact:CORE IRinvestors@ Media Contact:Phone: (703) 555-0123Email: media@ Non-GAAP Financial MeasuresStatements in this release include financial information presented in accordance with accounting principles generally accepted in the United States ("GAAP") and also include non-GAAP financial measures that are provided as additional information to enhance the overall understanding of the Company's current financial performance and not as an alternative to the consolidated interim financial statements presented in accordance with GAAP. Management uses these non-GAAP measures (earnings before interest, taxes, depreciation, and amortization ("EBITDA"), Adjusted EBITDA, Adjusted EBITDA margin, Free Cash Flow) to evaluate the Company's financial performance. These terms might not be calculated in the same manner as, and thus might not be comparable to, similarly titled measures reported by other companies. The financial information tables that accompany this press release include reconciliations of net income to non-GAAP financial measures. EBITDA, Adjusted EBITDA and Adjusted EBITDA margin provide a measure of the Company's operating results in a manner that is focused on the performance of the Company's core business on an ongoing basis, by removing the effects of non-operating and certain non-cash expenses. These non-operating and non-cash items are specifically identified in the reconciliations of GAAP measures to non-GAAP measures that accompany this release. Free Cash Flow provides useful information to investors about the amount of cash generated by the business that can be used for strategic opportunities and is computed as Cash Flows from Operating Activities less both the Purchase of Property and Equipment & Purchase of Intangible Assets. CYCURION, INC. AND ITS SUBSIDIARIESRECONCILIATION OF GAPP TO NON-GAAP MEASURES (Unaudited) Quarter ended March 31, 2025 2024 Net income (loss) $ (10,248,486 ) $ (312,475 ) Provision for income taxes - - Interest expense 178,890 231,475 Depreciation of fixed assets 1,709 2,197 Amortization of software development costs 8,333 - Gain on settlement of debt (141,653 ) - EBITDA (non-GAAP measure) $ (10,201,207 ) $ (78,803 ) Stock compensation expense 9,250,000 10,000 Merger-related expense 1,196,269 - Adjusted EBITDA (non-GAAP measure) $ 245,062 $ (68,803 )Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Sagteс Ignites AI Commercialization Surge with US$5 Million in Contracts, Targeting US$50 Million Pipeline in 12 Months
Breakthrough Robotics and CRM Deployments Set Stage for Scalable Recurring Revenue Across Southeast Asia and Hong Kong KUALA LUMPUR, Malaysia, June 06, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) ('Sagtec' or the 'Company'), the next-generation provider of customizable AI and automation platforms, today announced the signing of two major commercial contracts totaling US$5 million less than one week after the official launch of its AI-powered robotics platform. These early wins underscore an accelerated go-to-market approach and build momentum toward a commercial pipeline exceeding US$50 million over the next 12 months. This positions Sagtec as a rising leader in AI automation across the Asia-Pacific region. Key Highlights: US$2 Million Robotics Deployment Sagtec will deploy over 100 autonomous robotic units to a leading multi-brand restaurant group in Malaysia. This marks the initial phase of a nationwide rollout, expected to generate more than US$20 million in cumulative revenue over the next year under a Robotics-as-a-Service (RaaS) model. US$3 Million CRM Platform Contract The Company also secured a significant Customer Relationship Management (CRM) project with a prominent F&B operator. The solution features modules for loyalty management, points and credits tracking, inventory control, and workforce administration. This contract is projected to add over US$30 million in Software-as-a-Service (SaaS) revenue pipeline through regional expansion. Both contracts are powered by Sagtec's modular, full-stack AI platform, which integrates voice-activated robotics, POS systems, and real-time analytics. These milestone deployments validate Sagtec's dual-engine monetization strategy across RaaS and SaaS, generating scalable, high-margin recurring revenue. Strategic Outlook: With demand for automation accelerating in high-volume service sectors, Sagtec is actively expanding commercial engagements across Southeast Asia, Hong Kong, and the Gulf Cooperation Council (GCC) markets. The global service robotics market is projected to surpass US$90 billion, and Sagtec is strategically positioned to lead as a platform-native AI solution provider at scale. Momentum Metrics – Past 7 Days • 2 contracts signed worth US$5M • 100+ robotic units deployed • Targeting US$50M revenue pipeline • Enterprise client base expansion across 3 regions • New verticals in hospitality, retail, and foodtech unlocked 'This is more than early traction. It marks the beginning of an exponential monetization curve. Our combined RaaS and SaaS model is engineered for rapid scaling with enterprise adoption. By embedding AI directly into day-to-day operations, we are unlocking repeatable revenue at the infrastructure level, from robotics to real-time CRM analytics,' said Kevin Ng, Chairman, Executive Director, and Chief Executive Officer of Sagtec. About Sagtec Global Limited Sagtec is a leading provider of customizable software solutions, primarily serving the Food & Beverage (F&B) sector. The Company also offers software development, data management, and social media management to enhance operational efficiency across various industries. Additionally, Sagtec operates power-bank charging stations at 300 locations across Malaysia through its subsidiary, CL Technology (International) Sdn Bhd. For more information on the Company, please log on to Contact Information: Sagtec Global Limited Contact:Ng Chen LokChairman, Executive Director & Chief Executive OfficerPhone: +6011-6217 3661Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Heidelberg Pharma to Present at the Life Sciences Virtual Investor Forum June 12th
Heidelberg Pharma invites individual and institutional investors, as well as advisors and analysts, to attend online at LADENBURG, Germany, June 06, 2025 (GLOBE NEWSWIRE) -- Heidelberg Pharma AG (XETRA: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that Andreas Pahl, CEO of Heidelberg Pharma, will present live at the Life Sciences Virtual Investor Forum hosted by on June 12th, 2025. Heidelberg Pharma's lead candidate, HDP-101, a BCMA-targeting ADC with the novel payload Amanitin, is being evaluated in a Phase I/IIa clinical trial for the treatment of relapsed or refractory Multiple Myeloma. HDP-101 is showing promising results, including a prolonged complete response in a patient who had undergone extensive prior treatment. The patient has received continuous treatment with HDP-101 alone for over 19 months, showing excellent tolerability of the drug. In addition, promising biological activity and objective improvements were observed in several patients, underscoring the potential of HDP-101 as a treatment option for Multiple Myeloma. Dose escalation is continuing, and the study is advancing in cohort 8. Furthermore, the second candidate, HDP-102, a CD-37-targeting ADC with the novel payload Amanitin, has recently entered clinical development and the first patient has been dosed in a Phase I study for the treatment of non-Hodgkin lymphoma (NHL). DATE: June 12th TIME: 10:00 AM ETLINK: REGISTER HEREAvailable for 1x1 meetings: June 12th and 13th This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Heidelberg Pharma Announced First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025 PR: Heidelberg Pharma Amended Royalty Financing with HealthCare Royalty About Heidelberg Pharma Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and highly effective treatment of cancer. ADCs are antibody-drug conjugates that combine the specificity of antibodies with the efficacy of toxins to fight cancer. Selected antibodies are loaded with cytotoxic compounds, the so-called payloads, that are transported into diseased cells. Inside the cells, the toxins then unleash their effect and kill the diseased cells. Heidelberg Pharma uses several compounds and has built up an ADC toolbox that overcomes tumor resistance via numerous pathways and addresses different types of cancer using various antibodies. The goal is to develop targeted and highly effective ADCs for the treatment of a variety of malignant hematologic and solid tumors. Heidelberg Pharma is the first company to use the compound Amanitin from the green death cap mushroom in cancer therapy. The biological mechanism of action of the toxin represents a new therapeutic modality and is used as a compound in the Amanitin-based ADC technology, the so-called ATAC technology. The company is based in Ladenburg, Germany, and is listed on the Frankfurt Stock Exchange: ISIN DE000A11QVV0 / WKN A11QVV / Symbol HPHA. More information is available at ATAC® is a registered trademark of Heidelberg Pharma Research GmbH. ITAC™, ETAC™ are pending trademark applications of Heidelberg Pharma Research GmbH. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS:Heidelberg Pharma AG Sylvia Wimmer Director Corporate CommunicationsTel.: +49 89 41 31 38-29E-mail: investors@ Gregor-Mendel-Str. 22, 68526 Ladenburg Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
